TAXUS II和TAXUS IV研究PPT课件.pptVIP

TAXUS II: Late loss at 6 mo. and two yrs. TAXUS II: MACE at two years TAXUS II: MACE at two years (contin.) TAXUS IV: MACE at two years TAXUS IV: MACE at two years (contin.) TAXUS II and IV: two-year follow-up Among patients with single de novo coronary lesions, treatment with a paclitaxel-eluting stent continued to be associated with a reduction in TLR and TVR at 2 years compared with bare stent Consistent with the 6 month and 1 year data, TAXUS stents were not associated with a reduction in the clinical endpoints of death or MI at 2 years. The on-going REALITY trial is a head-to-head t